
Applied Clinical Trials

Applied Clinical Trials

Applied Clinical Trials
COO and CMO of BrainStorm, Ralph Kern, discusses how his company is overcoming challenges and advancing science in neurodegenerative disease.

Applied Clinical Trials

Applied Clinical Trials

Applied Clinical Trials
Chinese biotech companies are emerging as serious competitors in the global market as the country's drug development landscape claims industry attention once more.

Applied Clinical Trials

Applied Clinical Trials

Applied Clinical Trials

Applied Clinical Trials

Applied Clinical Trials

Applied Clinical Trials

Applied Clinical Trials

Applied Clinical Trials

Applied Clinical Trials

Applied Clinical Trials
The industry-wide shift towards RBx is not only reducing risk, but improving oversight and boosting proactive, predictive decision making, writes Cluepoints' CCO, Patrick Hughes.

Applied Clinical Trials

Applied Clinical Trials

Applied Clinical Trials

Applied Clinical Trials

Applied Clinical Trials

Applied Clinical Trials


Applied Clinical Trials

Applied Clinical Trials

Applied Clinical Trials

Applied Clinical Trials

Applied Clinical Trials
Dave Li explores the current information on the commercialization of advanced therapy medicinal products.

Applied Clinical Trials
The latest happenings of the past month in the industry, all in one place.